Shannon Weiman earned her PhD in Biomedical Sciences from the University of California, San Diego, specializing in microbiology and immunology. Prior to joining the Keystone Symposia team, she worked as a freelance writer for leaders in academic, industry and government research, including Stanford University’s Biomedical Innovation Initiative, the University of Colorado’s Biofrontiers Program, UCSF, the FDA and the American Society for Microbiology.
In June we wrapped up our 2024 conference season, aligning with the academic calendar. Altogether...
By Shannon Weiman
In 2023 we launched a new initiative to add health equity programming to select...
Last year we launched a new 2-day format for conferences on emerging topics, which were met with...
By Shannon Weiman
As climate change increasingly impacts society and human health around the globe,...
AI and Machine learning are transforming biomedical research at an astounding pace, enabling...
We are pleased to announce the launch of a new 2-day conference format for conferences on emerging...
As we wrap up our fall season, the community has taken to Twitter/X with rave reviews and...
In addition to covering emerging developments in vaccine science, design and technology, the ...
